Security key
87164U508
Theriva Biologics, Inc. - Common stock (TOVX)
CUSIP: 87164U508
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common stock
- Total 13F shares
- 291,012
- Total 13F value
- $126,275
- Share change
- +100,331
- SEC-reported price per share
- $0.43
- Number of holders
- 15
- Value change
- +$38,331
- Number of buys
- 9
- Number of sells
- 4
- Shares outstanding
- 9,600,143
Holder snapshot
6 signals
Security identity
1 source field
Report period
Q2 2025
Institutions
15
Top holders
10
TOVX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Theriva Biologics, Inc. SEC filings
Theriva Biologics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 87164U508
Recent filing periods:
Ownership snapshot
Top reported holders of TOVX - Theriva Biologics, Inc. - Common stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
CVI Investments, Inc.
Disclosed value leader
CVI Investments, Inc.
Comparable rows
11/12
Latest evidence
31 Mar 2025
13D/G
13F
3/4/5
Lead comparable stake: 4.9%
1 rows are not safely comparable across share classes.
13D/G row: CVI Investments, Inc.
Showing 1-6 of 12 holder rows.
Quick read
CVI Investments, Inc. leads the comparable SEC ownership view at 4.9%.
11 of 12 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
CVI Investments, Inc.
4.9%
Ikarian Capital, LLC
1.3%
BOOTHBAY FUND MANAGEMENT, LLC
0.37%
GEODE CAPITAL MANAGEMENT, LLC
0.19%
UBS Group AG
0.08%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 12 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| CVI Investments, Inc. |
13D/G
|
4.9%
|
$206,052
146,136 shares
|
$0 | 31 Dec 2024 |
| Ikarian Capital, LLC |
13F
Company
|
1.3%
|
$132,034
120,031 shares
|
— | 31 Mar 2025 |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
Company
|
0.37%
|
$39,161
35,601 shares
|
— | 31 Mar 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.19%
|
$20,554
18,683 shares
|
— | 31 Mar 2025 |
| UBS Group AG |
13F
Company
|
0.08%
|
$8,636
7,851 shares
|
— | 31 Mar 2025 |
| BlackRock, Inc. |
13F
Company
|
0.08%
|
$8,325
7,568 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
15
Shares
291,012
Rows available
15
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
10
Q2 2025 holders
15
Holder diff
5
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend